Version 1
: Received: 14 March 2024 / Approved: 15 March 2024 / Online: 15 March 2024 (14:40:24 CET)
How to cite:
Salomon, I.; Olivier, S.; Egide, N. Advancing Hepatitis C Elimination in Africa: Insights from Egypt. Preprints2024, 2024030935. https://doi.org/10.20944/preprints202403.0935.v1
Salomon, I.; Olivier, S.; Egide, N. Advancing Hepatitis C Elimination in Africa: Insights from Egypt. Preprints 2024, 2024030935. https://doi.org/10.20944/preprints202403.0935.v1
Salomon, I.; Olivier, S.; Egide, N. Advancing Hepatitis C Elimination in Africa: Insights from Egypt. Preprints2024, 2024030935. https://doi.org/10.20944/preprints202403.0935.v1
APA Style
Salomon, I., Olivier, S., & Egide, N. (2024). Advancing Hepatitis C Elimination in Africa: Insights from Egypt. Preprints. https://doi.org/10.20944/preprints202403.0935.v1
Chicago/Turabian Style
Salomon, I., Sibomana Olivier and Ndayambaje Egide. 2024 "Advancing Hepatitis C Elimination in Africa: Insights from Egypt" Preprints. https://doi.org/10.20944/preprints202403.0935.v1
Abstract
Hepatitis C virus (HCV) is a major public health threat associated with serious clinical consequences worldwide. The WHO reports an estimated 58 million people globally living with chronic hepatitis C virus (HCV) infection, with 1.5 million new cases and over 350,000 deaths annually due to HCV-related diseases. Despite the existence of multiple diagnostic methods, the accessibility of diagnosis and treatment is often hindered across the continent by limited resources, insufficient healthcare infrastructure, and low public awareness of Hepatitis C virus Hepatitis C virus infection is a major public health concern in African countries, which have the highest prevalence rates of HCV in the world (1–26%).
Egypt, African country which had the highest prevalence of Hepatitis C virus infection in the world. Its national hepatitis C elimination initiative emerges as an exemplary case of success an having screened over 60 million individuals, and treated more than 4 million, thereby markedly diminishing both the prevalence and incidence of the disease. The strategies employed by Egypt offer critical insights and adaptable frameworks for other African Countries facing analogous challenges.
The Aim of this Review is to highlight the triumphs and hurdles of Egypt's approach, while also providing strategic guidance for African Countries to accelerate the journey towards the eradication of hepatitis C.
Medicine and Pharmacology, Gastroenterology and Hepatology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
